DK
David Kim Portfolio
Invests via Paradigm Biocapital Advisors LP | Managed by Senai Asefaw, M.D., David Kim
Invests via Paradigm Biocapital Advisors LP
Managed by Senai Asefaw, M.D., David Kim
Automatically Tracked
David Kim Profile
With a strong foundation in technology and finance, David Kim has established himself as an influential figure in the startup ecosystem. His entrepreneurial journey began with the launch of multiple successful tech ventures, driving innovation in software solutions. As a seasoned operator, he emphasizes leveraging disruptive technologies to address market needs and create scalable business models. Kim's strategic leadership is evidenced by his ability to cultivate partnerships that accelerate growth and enhance competitive positioning within emerging sectors. Through mentorship roles and active investment participation, he remains committed to nurturing new talent and ideas that redefine industry standards.
With a strong foundation in technology and finance, David Kim has established himself as an influential figure in the startup ecosystem. His entrepreneurial journey began with the launch of multiple successful tech ventures, driving innovation in software solutions. As a seasoned operator, he emphasizes leveraging disruptive technologies to address market needs and create scalable business models. Kim's strategic leadership is evidenced by his ability to cultivate partnerships that accelerate growth and enhance competitive positioning within emerging sectors. Through mentorship roles and active investment participation, he remains committed to nurturing new talent and ideas that redefine industry standards.
Investment Philosophy & Strategy
David Kim's investment perspective thrives at the intersection of innovation and technology-driven growth. With a keen eye for identifying transformative startups, he actively seeks out companies poised to disrupt traditional markets. Emphasizing scalability, his approach combines rigorous analysis with an entrepreneurial mindset, focusing on building robust business models that respond dynamically to customer demands. His operational expertise allows him to assess potential partnerships and strategic alignments effectively, fostering environments ripe for rapid development. Kim champions ideas that challenge conventions and pave the way for future trends within the tech landscape.
David Kim's investment perspective thrives at the intersection of innovation and technology-driven growth. With a keen eye for identifying transformative startups, he actively seeks out companies poised to disrupt traditional markets. Emphasizing scalability, his approach combines rigorous analysis with an entrepreneurial mindset, focusing on building robust business models that respond dynamically to customer demands. His operational expertise allows him to assess potential partnerships and strategic alignments effectively, fostering environments ripe for rapid development. Kim champions ideas that challenge conventions and pave the way for future trends within the tech landscape.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
29.34%
Gain -0.64%
Monthly
0.39%
Yearly
4.78%
Drawdown
43.36%
$3.46B
Equity
Holdings
$3.46B
Investment
$2.82B
$996.15M
Profit -$26.61M
Realized
$359.61M
Unrealized
$636.54M
Dividends
$0
Goals
Avg. 26.5% completed goals
Yearly
Gain > 5% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
-0.64%
Profit
-$26.61M
Win %
74%
This Week
Compared To Last Week
Gain
-0.76%
Profit
-$26.61M
Win %
74%
This Month
Compared to last month
Gain
0.73%
Profit
$25.17M
Win %
74%
This Year
Compared to last year
Gain
-9.32%
Profit
-$252.44M
Win %
74%
ORIC Oric Pharmaceuticals Inc.
+5.75%
+$765,547.65 
TYRA Tyra Biosciences, Inc.
+5.55%
+$2.92M 
EYPT EyePoint Pharmaceuticals Inc.
+4.24%
+$1.67M 
LXEO Lexeo Therapeutics Inc.
+4.05%
+$1.05M 
BBOT BridgeBio Oncology Therapeutics, Inc.
+3.89%
+$251,781.77 
TNGX Tango Therapeutics Inc.
+3.76%
+$4.49M 
EWTX Edgewise Therapeutics, Inc.
+2.65%
+$6.63M 
ORKA Oruka Therapeutics, Inc.
+2.07%
+$3.29M 
VOR Vor Biopharma Inc.
+1.92%
+$472,500 
ASMB Assembly Biosciences Inc.
+1.91%
+$286,057.93 
MANE Veradermics Inc.
+1.77%
+$876,750 
IVA Inventiva S.A.
+1.32%
+$200,000 
VRDN Viridian Therapeutics Inc.
+1.3%
+$661,267.53 
CYTK Cytokinetics, Incorporated
+1.27%
+$1.3M 
OLMA Olema Pharmaceuticals Inc.
+1.23%
+$962,469.12 
INSM Insmed Inc.
+1.17%
+$1.42M 
BLTE Belite Bio, Inc.
+0.96%
+$1.46M 
URGN Urogen Pharma Ltd.
+0.75%
+$374,868.78 
PCVX Vaxcyte, Inc.
+0.36%
+$814,813.4 
ERAS Erasca, Inc.
+0.29%
+$415,708.08 
SYRE Spyre Therapeutics, Inc.
+0.03%
+$39,145.32 
ACLX Arcellx, Inc.
0%
$0 
RVMDW Revolution Medicines, Inc. Warrant
0%
$0 
TERN Terns Pharmaceuticals, Inc.
0%
$0 
ABVX Abivax SA ADR
-4.28%
-$3.34M 
APGE Apogee Therapeutics Inc.
-1.31%
-$1.58M 
SRRK Scholar Rock Holding Corporation
-1.14%
-$625,300.8 
TARS Tarsus Pharmaceuticals Inc.
-1.05%
-$1.69M 
GPCR Structure Therapeutics Inc.
-0.85%
-$201,756.19 
KLRS Kalaris Therapeutics, Inc.
-0.69%
-$21,000 
GMAB Genmab A/S Sponsored ADR
-0.63%
-$1.27M 
MIRM Mirum Pharmaceuticals Inc.
-0.2%
-$121,875 
MAZE Maze Therapeutics Inc.
-0.17%
-$109,778.7 
NUVL Nuvalent, Inc.
-0.16%
-$1.06M 
CNTA Centessa Pharmaceuticals plc American Depositary Receipt
-0.13%
-$178,702.4 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 486 | Longs Won 233/486 47% | Profit Factor 2.36 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $11.92M |
| Average Win $7.41M | Best Trade (Jun 14) $110.24M | Sharpe Ratio -2.04 |
| Average Loss -$2.89M | Worst Trade (Jun 14) -$82.38M | Z-Score -0.92 (64.13%) |
| Commissions $0 | Avg. Trade Length 11m 2w 4d | Expectancy $2.05M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 1,198 | 1,078 | 958 | 838 | 719 | 599 | 479 | 359 | 240 | 120 |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
